"Treatment Use of ECMO In Pregnancy or Peripartum Patient."

Completed

• Conditions: Cardiogenic Shock; Peripartum Cardiomyopathy; Complication, Pregnancy
• Interventions: Device: Extracorporeal Membrane Oxygenation

• Registration Number: NCT04144660
• Lead Sponsor: Sarah Thordsen

Brief Summary

The goal of this study is to describe the use of ECMO (Extracorporeal Membrane Oxygenation) in the pregnant or peripartum patient.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-10-28
• Study First Submitted: 2019-10-28
• Study First Submitted QC: 2019-10-28
• Study First Posted: 2019-10-30
• Primary Completion: 2020-03-31
• Study Completion: 2020-03-31
• Status Verified: 2020-11
• Last Update Submitted: 2020-11-19
• Last Update Posted: 2020-11-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 5

Inclusion Criteria

1. Female
2. Age 18 years or greater at the time of ECMO treatment.
3. Pregnant or within 6 months post-partum at the time of ECMO cannulation

Exclusion Criteria

1. No history of pregnancy.
2. No treatment with ECMO.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Cardiogenic Shock Treated with ECMO	Extracorporeal Membrane Oxygenation	This cohort of participants required clinical intervention with ECMO for treatment of their index cardiogenic shock episode while pregnant or post delivery of their infant.

Primary Outcome Measures

Name	Time	Method
Clinical Outcome of Mother	Time of diagnosis -Six Month Survival Rate	Describe clinical course of pregnant or recently postpartum patients with cardiogenic shock treated with ECMO, including the rate of neonate survival

Trial Locations

Locations (1)

Medical College of Wisconsin; 🇺🇸 Milwaukee, Wisconsin, United States